Overview

Study In Patients With Dyslipidaemia

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
Study in patients with dyslipidaemia.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline